Eli Lilly and Company LLY
NYSE · United States · Health Technology
$1,157.08-27.55 (-2.33%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | 8.38 | 6.40 | +30.9% | $22.97B | +10.3% | +6.8%$1,115.68→$1,191.94 |
| Q1 2026 | 2026-04-30 | 8.55 | 6.79 | +25.9% | — | — | +13.2%$851.21→$963.33 |
| Q4 2025 | 2026-02-04 | 7.54 | 6.91 | +9.1% | — | — | +1.7%$1,003.46→$1,020.84 |
| Q3 2025 | 2025-10-30 | 7.02 | 5.89 | +19.2% | — | — | +6.1%$813.53→$862.86 |
| Q2 2025 | 2025-08-07 | 6.31 | 5.59 | +12.9% | — | — | — |
| Q1 2025 | 2025-05-01 | 3.34 | 3.46 | -3.5% | — | — | — |
| Q4 2024 | 2025-02-06 | 5.32 | 5.07 | +4.9% | — | — | — |
| Q3 2024 | 2024-10-30 | 1.18 | 1.47 | -19.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.